Safety and effectiveness of a biosimilar somatropin (Cinnatropin®) in children and adolescents receiving growth hormone therapy over 1 year: a registry-based phase IV study

• DOI: 10.1007/s00431-025-06056-1
• Publication Date: 2025-03-05T08:58:11Z
• Authors: Ali Rabbani; Maryam Razzaghy-Azar; Zohreh Karamizadeh; Mahin Hashemipour; Rahim Vakili; Aria Setoodeh; Mohammadreza Alaei; Robabeh Gherghere...; Shadab Salehpour; Majid Aminzadeh; Ali Talea; Hossein Zaeri; Mahmoud Ghasemi; Forough Saki; Araz Sabzvari; Hamidreza Kafi